If the health care bill does not have ‘death panels’ why is this happening in a similar system?
Patients in England and Wales denied drug available in Scotland.
The Government’s drugs rationing body, the National Institute for Health and Clinical Excellence (Nice), has provisionally said that it does not intend to recommend the use of the drug, called Tocilizumab, or Roactemra.
Nice claims that the £9,000 a year drug, for rheumatoid arthritis, has not proved that it is cost effective.
